CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rooney, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rooney, R. J.
Cell Growth & Differentiation Vol. 12, 505-516, October 2001
© 2001 American Association for Cancer Research

Cell Cycle Attenuation by p120E4F Is Accompanied by Increased Mitotic Dysfunction1

Robert J. Rooney2

Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710

In addition to their well-established roles at the G1-S checkpoint, recent reports support a role for universal cyclin-dependent kinase (CDK) inhibitors in the control of G2-M and suggest that their induction may stimulate the occurrence of endomitosis or polyploidy in a number of physiological settings. In this report, the stable expression of the p120E4F transcription factor, which attenuates G1-S progression by elevating p21WAF1 and p27KIP1 protein levels, was shown to also interfere with the regulation of G2-M and cytokinesis. Exponentially growing cultures of p120E4F-expressing fibroblast cell lines had reduced levels of CDC2 kinase activity, elevated levels of Cyclin B1 protein, and continuously generated a subpopulation of tetraploid cells and elevated numbers of multinucleated cells. Coexpression of activated Ras, which stimulates Cyclin D1 expression and G1-S-specific cyclin-CDK kinase activities, alleviated these effects without reducing p21WAF1 or p27KIP1 protein levels; p120E4F/ras-expressing cell lines contained reduced levels of Cyclin B1 protein, a restoration of Cyclin B-CDC2 kinase activity to control levels, and exhibited no increase of tetraploid or multinucleated cells. Interestingly, changes in the expression of Cyclin B1 and, to a lesser extent, CDC2 were primarily regulated by post-transcriptional mechanisms. The results indicate that mechanisms which moderately elevate CDK inhibitor levels can reduce CDC2 kinase activity to the point of impeding normal G2-M function and suggest that two molecular determinants commonly associated with the induction of polyploidy in a number of tissues, i.e., elevated levels of universal CDK inhibitors and sustained CDK2 kinase activity, may be solely sufficient to initiate endomitosis.




This article has been cited by other articles:


Home page
JEMHome page
E. Hatchi, G. Rodier, M. Lacroix, J. Caramel, O. Kirsh, C. Jacquet, E. Schrepfer, S. Lagarrigue, L. K. Linares, G. Lledo, et al.
E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells
J. Exp. Med., July 4, 2011; 208(7): 1403 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Chagraoui, S. L. Niessen, J. Lessard, S. Girard, P. Coulombe, M. Sauvageau, S. Meloche, and G. Sauvageau
E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells
Genes & Dev., August 1, 2006; 20(15): 2110 - 2120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Le Cam, M. Lacroix, M. A. Ciemerych, C. Sardet, and P. Sicinski
The E4F Protein Is Required for Mitotic Progression during Embryonic Cell Cycles
Mol. Cell. Biol., July 15, 2004; 24(14): 6467 - 6475.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Fenton, A. Dallol, A. Agathanggelou, L. Hesson, J. Ahmed-Choudhury, S. Baksh, C. Sardet, R. Dammann, J. D. Minna, J. Downward, et al.
Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor Gene
Cancer Res., January 1, 2004; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. A. Tessari, M. Gostissa, S. Altamura, R. Sgarra, A. Rustighi, C. Salvagno, G. Caretti, C. Imbriano, R. Mantovani, G. Del Sal, et al.
Transcriptional Activation of the Cyclin A Gene by the Architectural Transcription Factor HMGA2
Mol. Cell. Biol., December 15, 2003; 23(24): 9104 - 9116.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. Rizos, E. Diefenbach, P. Badhwar, S. Woodruff, T. M. Becker, R. J. Rooney, and R. F. Kefford
Association of p14ARF with the p120E4FTranscriptional Repressor Enhances Cell Cycle Inhibition
J. Biol. Chem., February 14, 2003; 278(7): 4981 - 4989.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-L. Xie, A. J. van Wijnen, C. M. van der Meijden, J. L. Stein, and G. S. Stein
Forced Expression of the Interferon Regulatory Factor 2 Oncoprotein Causes Polyploidy and Cell Death in FDC-P1 Myeloid Hematopoietic Progenitor Cells
Cancer Res., May 1, 2002; 62(9): 2510 - 2515.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2001 by the American Association of Cancer Research.